首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1459631

全球免疫球蛋白市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Immunoglobulins Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年03月01日 | 出版商:

Value Market Research | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球免疫球蛋白市場需求預計將從 2023 年的 176.5 億美元達到 2032 年近 325.3 億美元的市場規模，2024-2032 年研究期間CAGR為 7.03%。

免疫球蛋白或抗體是免疫系統產生的蛋白質，用於識別和中和細菌、病毒和毒素等外來物質。它們透過與特定抗原結合並標記它們以被其他免疫細胞破壞，在人體防禦感染和疾病方面發揮著至關重要的作用。免疫球蛋白分為不同的類別（IgM、IgG、IgA、IgD 和 IgE），每種類別都有獨特的身體功能和分佈。免疫球蛋白產生的缺陷或異常可能導致免疫失調並增加感染的易感性，這強調了維持健康的免疫系統的重要性。

市場動態

有幾個因素推動了免疫球蛋白市場的發展，包括免疫缺陷疾病的日益流行、治療和診斷用途的不斷成長以及生物技術和蛋白質工程的進步。免疫球蛋白，也稱為抗體，在免疫系統防禦感染和疾病方面發揮著至關重要的作用，推動了對基於免疫球蛋白的療法在治療免疫缺陷性疾病、自體免疫疾病和傳染病方面的需求。此外，擴大採用基於免疫球蛋白的診斷方法進行疾病篩檢、監測和研究應用，進一步推動了市場的成長。此外，重組DNA技術和基因改造動物平台等生物製造技術的進步使得治療性免疫球蛋白的生產具有更高的功效、安全性和可擴展性。此外，隨著醫療保健提供者和患者尋求創新的治療方案和診斷工具，新型免疫球蛋白療法和診斷測定的監管批准和市場授權推動了市場擴張。然而，發展中地區獲得醫療保健服務的機會有限、學名藥免疫球蛋白產品的定價壓力以及產品核准方面的監管挑戰可能會阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球免疫球蛋白市場的每個細分市場進行了包容性評估。免疫球蛋白產業的成長和趨勢為本研究提供了整體方法。

市場區隔

免疫球蛋白市場報告的這一部分提供了國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按申請

神經病學
免疫學
血液學
其他

依給藥途徑

靜脈
皮下
肌肉注射

按最終用戶

醫院
診所
居家護理

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲免疫球蛋白市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。免疫球蛋白市場的主要參與者包括 Shire、CSL Behring、Kedrion Biopharma Inc.、Grifols, SA、Octapharma、China Biologic Products Holdings, Inc.、Biotest AG、Sanquin、LFB SA。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：免疫球蛋白公司的競爭格局

免疫球蛋白市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Shire

公司簡介
公司收入
產品
最近的發展

CSL Behring

公司簡介
公司收入
產品
最近的發展

Kedrion Biopharma Inc.

公司簡介
公司收入
產品
最近的發展

Grifols SA

公司簡介
公司收入
產品
最近的發展

Octapharma

公司簡介
公司收入
產品
最近的發展

China Biologic Products Holdings Inc.

公司簡介
公司收入
產品
最近的發展

Biotest AG

公司簡介
公司收入
產品
最近的發展

Sanquin

公司簡介
公司收入
產品
最近的發展

LFB SA

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112114030

The global demand for Immunoglobulins Market is presumed to reach the market size of nearly USD 32.53 Billion by 2032 from USD 17.65 Billion in 2023 with a CAGR of 7.03% under the study period 2024 - 2032.

Immunoglobulins or antibodies are proteins the immune system produces to identify and neutralize foreign substances such as bacteria, viruses, and toxins. They play a crucial role in the body's defense against infections and diseases by binding to specific antigens and marking them for destruction by other immune cells. Immunoglobulins are categorized into different classes (IgM, IgG, IgA, IgD, and IgE), each with unique bodily functions and distribution. Deficiencies or abnormalities in immunoglobulin production can lead to immune disorders and increase susceptibility to infections, emphasizing the significance of maintaining a healthy immune system.

MARKET DYNAMICS

Several factors drive the market for immunoglobulins, including the increasing prevalence of immunodeficiency disorders, growing applications in therapeutic and diagnostic uses, and advancements in biotechnology and protein engineering. Immunoglobulins, also known as antibodies, play a crucial role in the immune system's defense against infections and diseases, driving demand for immunoglobulin-based therapies in treating immunodeficiency disorders, autoimmune diseases, and infectious diseases. Additionally, the growing adoption of immunoglobulin-based diagnostics for disease screening, monitoring, and research applications further fuels market growth. Moreover, advancements in biomanufacturing technologies, such as recombinant DNA technology and transgenic animal platforms, enable the production of therapeutic immunoglobulins with improved efficacy, safety, and scalability. Furthermore, regulatory approvals and market authorizations for novel immunoglobulin therapies and diagnostic assays drive market expansion as healthcare providers and patients seek innovative treatment options and diagnostic tools. However, limited access to healthcare services in developing regions, pricing pressures from generic immunoglobulin products, and regulatory challenges in product approval are likely to hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of immunoglobulins. The growth and trends of immunoglobulins industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the immunoglobulins market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Neurology
Immunology
Hematology
Others

By Route Of Administration

Intravenous
Subcutaneous
Intramuscular

By End-User

Hospitals
Clinics
Homecare

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Immunoglobulins market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Immunoglobulins market include Shire, CSL Behring, Kedrion Biopharma Inc., Grifols, S.A., Octapharma, China Biologic Products Holdings, Inc., Biotest AG, Sanquin, LFB SA. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . IMMUNOGLOBULINS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Route of Administration
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL IMMUNOGLOBULINS MARKET ANALYSIS BY APPLICATION

5.1 Overview by Application
5.2 Historical and Forecast Data
5.3 Analysis by Application
5.4 Neurology Historic and Forecast Sales by Regions
5.5 Immunology Historic and Forecast Sales by Regions
5.6 Hematology Historic and Forecast Sales by Regions
5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL IMMUNOGLOBULINS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

6.1 Overview by Route of Administration
6.2 Historical and Forecast Data
6.3 Analysis by Route of Administration
6.4 Intravenous Historic and Forecast Sales by Regions
6.5 Subcutaneous Historic and Forecast Sales by Regions
6.6 Intramuscular Historic and Forecast Sales by Regions

7 . GLOBAL IMMUNOGLOBULINS MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Clinics Historic and Forecast Sales by Regions
7.6 Homecare Historic and Forecast Sales by Regions

8 . GLOBAL IMMUNOGLOBULINS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE IMMUNOGLOBULINS COMPANIES

9.1. Immunoglobulins Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF IMMUNOGLOBULINS INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Shire
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. CSL Behring
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Kedrion Biopharma Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Grifols S.A.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Octapharma
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. China Biologic Products Holdings Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Biotest AG
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Sanquin
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. LFB SA
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments